146 related articles for article (PubMed ID: 2261002)
1. Catabolic effects of muramyl dipeptide on rabbit chondrocytes.
Ikebe T; Iribe H; Hirata M; Yanaga F; Koga T
Arthritis Rheum; 1990 Dec; 33(12):1801-6. PubMed ID: 2261002
[TBL] [Abstract][Full Text] [Related]
2. Synergism between muramyl dipeptide and lipopolysaccharide in the inhibition of glycosaminoglycan synthesis in cultured rat costal chondrocytes.
Ikebe T; Hirata M; Yanaga F; Koga T
Ann Rheum Dis; 1993 Jan; 52(1):32-6. PubMed ID: 8427511
[TBL] [Abstract][Full Text] [Related]
3. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endogenous pyrogen-induced fever by a muramyl dipeptide derivative.
Parant M; Riveau G; Parant F; Chedid L
Am J Physiol; 1984 Sep; 247(3 Pt 1):C169-74. PubMed ID: 6476105
[TBL] [Abstract][Full Text] [Related]
5. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
[TBL] [Abstract][Full Text] [Related]
6. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
[TBL] [Abstract][Full Text] [Related]
7. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 1, a mediator of immunoadjuvant peptidoglycans.
Guenounou M; Vacheron F; Nauciel C
Comp Immunol Microbiol Infect Dis; 1985; 8(3-4):273-84. PubMed ID: 2868825
[TBL] [Abstract][Full Text] [Related]
9. Somnogenic activity of muramyl peptide-derived immune adjuvants.
Johannsen L; Obál F; Kapás L; Kovalzon V; Krueger JM
Int J Immunopharmacol; 1994 Feb; 16(2):109-16. PubMed ID: 8181899
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
Zídek Z; Kameníková L; Buchar E; Janků I; Masek K
Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines.
Iribe H; Koga T; Onoue K; Kotani S; Kusumoto S; Shiba T
Cell Immunol; 1981 Oct; 64(1):73-83. PubMed ID: 7028277
[No Abstract] [Full Text] [Related]
12. Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.
Fraser-Smith EB; Waters RV; Matthews TR
Infect Immun; 1982 Jan; 35(1):105-10. PubMed ID: 7054119
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1-induced sleep and febrile responses differentially altered by a muramyl dipeptide derivative.
Cady AB; Riveau G; Chedid L; Dinarello CA; Johannsen L; Krueger JM
Int J Immunopharmacol; 1989; 11(8):887-93. PubMed ID: 2613394
[TBL] [Abstract][Full Text] [Related]
14. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
Pratta MA; Ackerman NR; Arner EC
Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
[TBL] [Abstract][Full Text] [Related]
15. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.
Polanski M; Karnovsky ML
J Neuroimmunol; 1992 Mar; 37(1-2):149-60. PubMed ID: 1532180
[TBL] [Abstract][Full Text] [Related]
17. [The immunostimulating activity of muramyl dipeptide and its derivatives].
Karsonova MI; Andronova TM; Pinegin BV; Khaitov RM
Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):104-10. PubMed ID: 10852007
[No Abstract] [Full Text] [Related]
18. Biological activity of anomeric pairs of lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine.
Kalyuzhin OV; Zemlyakov AE; Kalina NG; Mulik EL; Kuzovlev FN; Makarova OV
Bull Exp Biol Med; 2008 May; 145(5):623-5. PubMed ID: 19145298
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis of N-acetyl-muramyl-dipeptide--an immunoadjuvant].
Chen ZY; Chen LF; Gong XQ
Yao Xue Xue Bao; 1982 Jun; 17(6):425-30. PubMed ID: 7148465
[No Abstract] [Full Text] [Related]
20. Differential effects of parathyroid hormone and somatomedin-like growth factors on the sizes of proteoglycan monomers and their synthesis in rabbit costal chondrocytes in culture.
Hiraki Y; Yutani Y; Takigawa M; Kato Y; Suzuki F
Biochim Biophys Acta; 1985 Jun; 845(3):445-53. PubMed ID: 3890962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
